AMNON PELED

Prof. AMNON PELED

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2006 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
SAShani Avniel
Shani Avniel
ZAZaretski Arik
Zaretski Arik
AMAlex Maly
Alex Maly
ASAssa Sagie
Assa Sagie
HBHanna Ben Basst
Hanna Ben Basst
APAMNON PELED
AMNON PELED

23 March 2004 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
OWOri Wald
Ori Wald
OPOrit Pappo
Orit Pappo
RSRifaat Safadi
Rifaat Safadi
MDMichal Dagan‐Berger
Michal Dagan‐Berger
KBKatia Beider
Katia Beider
APAMNON PELED
AMNON PELED
Chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infection is accompanied by inflammation and fibrosis eventually leading to cirrhosis. The chemokine CXCL12 is involved in chronic inflammatory conditions. The role of the CXCL12/CXCR4 pathway in HCV‐ and HBV‐associated liver inflammation and fibrosis was therefore studied. The levels and tissue localization of CXCL12 in liver and plasma of HCV and HBV patients were tested using immunohistochemistry and ELISA. The expression and function of CXCR4 on liver‐infiltrating lymphocytes (LIL) were tested by FACS and transwell migration assays. We found that CXCL12 is expressed by bile duct epithelial cells in normal liver tissue. Bile duct proliferation and liver fibrosis in chronic HCV and HBV infection result in the anatomical re‐distribution of CXCL12 in the liver. Moreover, CXCL12 is up‐regulated in the endothelium of neo‐blood‐vessels formed in active inflammatory foci and is significantly elevated, compared with controls, in the plasma of patients with advanced liver fibrosis. Complementing these observations were others indicating that over 50% of LIL express CXCR4 and, in response to CXCL12, migrated and adhered to fibronectin. These observations suggest an important role for the CXCL12/CXCR4 pathway in recruitment and retention of immune cells in the liver during chronic HCV and HBV infection.

1 January 2013 in Theranostics
Verified
Journal Article
Open access
APAMNON PELED
AMNON PELED
STSigal Tavor
Sigal Tavor
The Chemokine receptor CXCR4 and its ligand stromal derived factor-1 (SDF-1/CXCL12) are important players involved in cross-talk between leukemia cells and the bone marrow (BM) microenvironment. CXCR4 expression is associated with poor prognosis in AML patients with and without the mutated FLT3 gene.

1 September 2018 in Cytokine
Verified
Journal Article
Closed access
APAMNON PELED
AMNON PELED
SKShiri Klein
Shiri Klein
KBKatia Beider
Katia Beider
JBJan A. Burger
Jan A. Burger
MAMichal Abraham
Michal Abraham

1 September 2007 in Stem Cells
Verified
Journal Article
Open access
PDF file
MAMichal Abraham
Michal Abraham
KBKatia Biyder
Katia Biyder
MBMichal Begin
Michal Begin
HWHanna Wald
Hanna Wald
IWIdo D. Weiss
Ido D. Weiss
APAMNON PELED
AMNON PELED
An increase in the number of stem cells in blood following mobilization is required to enhance engraftment after high-dose chemotherapy and improve transplantation outcome. Therefore, an approach that improves stem cell mobilization is essential. The interaction between CXCL12 and its receptor, CXCR4, is involved in the retention of stem cells in the bone marrow. Therefore, blocking CXCR4 may result in mobilization of hematopoietic progenitor and stem cells. We have found that the CXCR4 antagonist known as 4F-benzoyl-TN14003 (T-140) can induce mobilization of hematopoietic stem cells and progenitors within a few hours post-treatment in a dose-dependent manner. Furthermore, although T-140 can also increase the number of white blood cells (WBC) in blood, including monocytes, B cells, and T cells, it had no effect on mobilizing natural killer cells. T-140 was found to efficiently synergize with granulocyte colony-stimulating factor (G-CSF) in its ability to mobilize WBC and progenitors, as well as to induce a 660-fold increase in the number of erythroblasts in peripheral blood. Comparison between the CXCR4 antagonists T-140 and AMD3100 showed that T-140 with or without G-CSF was significantly more potent in its ability to mobilize hematopoietic stem cells and progenitors into blood. These results demonstrate that different CXCR4 antagonists may have different therapeutic potentials. Disclosure of potential conflicts of interest is found at the end of this article.

15 April 2006 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
OWOri Wald
Ori Wald
IWIdo D. Weiss
Ido D. Weiss
HWHanna Wald
Hanna Wald
HSHadas Shoham
Hadas Shoham
YBYochay Bar-Shavit
Yochay Bar-Shavit
APAMNON PELED
AMNON PELED
The mechanism(s) that regulates NK cell mobilization and the significance of this process to NK cell activity are unknown. After Con A-induced hepatitis, NK cells are mobilized from the spleen and bone marrow into the periphery in an IFN-γ-dependent fashion. Intraperitoneal administration of IFN-γ stimulates the mobilization of NK cells into the circulation, but not their cell death or proliferation. Increased number of circulating NK cells was coupled with their accumulation in the peritoneum, liver, and tumor-bearing lung tissue. Furthermore, increased number of NK cells in the lung reduced metastasis of Lewis lung carcinoma cells (3LL cell line) resulting in significantly extended NK-dependent survival. Mobilization of NK cells was specific and required the presence of T cells. Moreover, mobilization and migration of spleen NK cells in response to IFN-γ treatment is dependent on the chemokine receptor CXCR3. Mechanistic insights regarding the role of IFN-γ in the regulation of NK cell mobilization and their accumulation at sites of tumor metastasis may lead to the development of novel immunotherapy for cancer.